Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database
This study revealed the current state of antipsychotic medications for MDOs admitted to forensic psychiatric wards in Japan. Future studies are needed to clarify the relevance of antipsychotic medications in the prognosis of MDOs.
Authors
- Koji Takeda (ORCID: https://orcid.org/0009-0007-0433-0145)
- Yuki Kako (ORCID: https://orcid.org/0000-0002-7841-5498)
- Yuji Yamada (ORCID: https://orcid.org/0000-0002-2169-1635)
- Hiroko Kashiwagi (ORCID: https://orcid.org/0000-0003-4029-7868)
- Ryotaro Kubota (ORCID: https://orcid.org/0009-0006-8349-9311)
- Keisuke Takanobu (ORCID: https://orcid.org/0000-0001-5044-9699)
- Toshiaki Kono
- Junko Koike
- Naotsugu Hirabayasi
- Ryo Naoe
Institutions
- National Center of Neurology and Psychiatry (JP)
- Hokkaido University Hospital (JP)
- National Institute of Mental Health (JP)
Publication Details
- Journal
- Neuropsychopharmacology Reports
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1002/npr2.12505
- Citations
- 3
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Ministry of Health, Labour and Welfare
- Meiji Seika Pharma
- Otsuka Pharmaceutical
- H. Lundbeck A/S
- Novartis Pharma